Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer

JAMA Oncology

Volumn 4, Issue 6, 2018, Pages 798-804

  Caan, Bette J ^a   Cespedes Feliciano, Elizabeth M ^a   Prado, Carla M ^b   Alexeeff, Stacey ^a   Kroenke, Candyce H ^a   Bradshaw, Patrick ^a   Quesenberry, Charles P ^a   Weltzien, Erin K ^a   Castillo, Adrienne L ^a   Olobatuyi, Taiwo A ^b   Chen, Wendy Y ^c  

^a DIVISION OF RESEARCH   (United States)

^b Food and Nutritional Sciences ^*  (Canada)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; BODY COMPOSITION; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LOW MUSCLE RADIODENSITY; MAJOR CLINICAL STUDY; MUSCLE CHARACTERISTICS AND FUNCTIONS; MUSCLE TONE; OBESITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SARCOPENIA; SOCIAL STATUS; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR CLASSIFICATION; ADOLESCENT; BREAST TUMOR; CAUSE OF DEATH; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC IMAGING; KAPLAN MEIER METHOD; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SKELETAL MUSCLE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY MASS INDEX; BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM STAGING; OBESITY; ORGAN SIZE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOPENIA; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 85048616069     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2018.0137     Document Type: Article

References (22)

1. Ligibel JA, Wollins D. American Society of Clinical Oncology obesity initiative: rationale, progress, and future directions. J Clin Oncol. 2016;34(35): 4256-4260.
2. Kwan ML, Chen WY, Kroenke CH, et al. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012;132(2): 729-739.
3. Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901-1914.
4. Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL. Association between body mass index (BMI) and cancer survival in a pooled analysis of 22 clinical trials. Cancer Epidemiol Biomarkers Prev. 2017;26(1):21-29.
5. Del Fabbro E, Parsons H, Warneke CL, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17 (10):1240-1245.
6. Iwase T, Sangai T, Nagashima T, et al. Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Med. 2016;5(1):41-48.
7. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15 (8):2920-2926.
8. Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock MCJM, Levin MD. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast. 2017;31:9-15.
9. Shachar SS, Deal AM, Weinberg M, et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res. 2017;23(3):658-665.
10. Villaseñor A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv. 2012;6(4):398-406.
11. Slice Omatic [computer program]. Version 5.0. Montreal, Quebec, Canada: TomoVision; 2015.
12. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985). 2004;97(6):2333-2338.
13. Williams BA, Mandrekar JA, Mandrekar SJ, et al. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Rochester, MN: Mayo Foundation; 2006.
14. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013; 31(12):1539-1547.
15. Prado CM, Lieffers JR,McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008;9(7): 629-635.
16. Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal. 1999;(30):253-270.
17. World Health Organization. Global Database on Body Mass Index. 2017. http://www.who.int/nutrition/databases/bmi/en/. Accessed February 5, 2018.
18. Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol. 2017;3(12):e172319.
19. Malietzis G, Lee GH, Bernardo D, et al. The prognostic significance and relationship with body composition of CCR7-positive cells in colorectal cancer. J Surg Oncol. 2015;112(1):86-92.
20. Malietzis G, Johns N, Al-Hassi HO, et al. Low muscularity andmyosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg. 2016;263(2):320-325.
21. Hubbard JM, Cohen HJ, Muss HB. Incorporating biomarkers into cancer and aging research. J Clin Oncol. 2014;32(24):2611-2616.
22. Porter Starr KN, Pieper CF, Orenduff MC, et al. Improved function with enhanced protein intake per meal: A pilot study of weight reduction in frail, obese older adults. J Gerontol A Biol Sci Med Sci. 2016;71(10):1369-1375.